GnRH agonist
Goserelin clinical trials
Answer
Goserelin has 449 registered trials: 123 running, 184 completed, 51 stopped early. 106 posted results.
Trial registerClinicalTrials.gov and EU CTIS, read 2026-10-03
| Trial | Title | Status | Phase | Registered | Results |
|---|---|---|---|---|---|
| NCT05827081 Trial register | Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | currently recruiting participants | - | 2023-04-24 | - |
| NCT02115282 Trial register | Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic | running, but no longer enrolling | - | 2014-04-16 | Posted |
| NCT05161195 Trial register | Roll-over Study to Allow Continued Access to Ribociclib | running, but no longer enrolling | - | 2021-12-17 | - |
| NCT07460752 Trial register | Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor P | currently recruiting participants | - | 2026-03-10 | - |
| 2022-501024-20-00 Trial register | CAMBRIA-1: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant (AZD9833, a Next Generation, Oral S | Not stated | 3 | - | - |
| 2026-525328-10-00 Trial register | A TWO-STAGE, SINGLE-ARM, PHASE II STUDY OF ZONGERTINIB PLUS FULVESTRANT IN PARTICIPANTS WITH HORMONE RECEPTOR-POSITIVE/HER2-NEGATIVE ADVANCED BREAST CANCER HARB | Not stated | 2 | - | - |
| NCT01723774 Trial register | PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer | running, but no longer enrolling | - | 2012-11-08 | Posted |
| NCT07287098 Trial register | A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early | currently recruiting participants | - | 2025-12-17 | - |
| NCT05003752 Trial register | Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer | running, but no longer enrolling | - | 2021-08-12 | - |
| NCT06582446 Trial register | Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial) | currently recruiting participants | - | 2024-09-03 | - |
| 2024-519655-28-00 Trial register | OPTIMA YOUNG : Optimal Personalized Treatment of early breast cancer using Multi-parameter Analysis : focus on YOUNGer women | Not stated | 3 | - | - |
| 2025-523258-15-00 Trial register | J2J-MC-JZLL - preEMBER: A Phase 2, Open-label Study Evaluating Imlunestrant in Premenopausal Women with Estrogen Receptor-Positive, HER2-Negative Breast Cancer. | Not stated | 2 | - | - |
| NCT03070886 Trial register | Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery | running, but no longer enrolling | - | 2017-03-06 | - |
| NCT05870579 Trial register | [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer | running, but no longer enrolling | - | 2023-05-23 | - |
| 2023-503990-39-00 Trial register | SERENA-6: A Phase III, Double-blind, Randomised Study to Assess Switching to AZD9833 (a Next Generation, Oral SERD) + CDK4/6 Inhibitor vs Continuing Aromatase I | Not stated | 3 | - | - |
| 2023-503995-26-00 Trial register | SERENA-4: A Randomised, Multicentre, Double-Blind, Phase 3 Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrazole plus Palbociclib for the Treatmen | Not stated | 3 | - | - |
| 2023-509494-23-00 Trial register | DARIUS : A RANDOMIZED NON-COMPARATIVE PHASE II MULTICENTRIC TRIAL ON SHORT TERM DAROLUTAMIDE (ODM-201) CONCOMITANT TO RADIATION THERAPY FOR PATIENTS WITH INTERM | Not stated | 2 | - | - |
| NCT07801898 Trial register | Neoadjuvant Endocrine Therapy Combined With Chemotherapy in ER-positive, HER2-negative Stage I-III Breast Cancer | not yet recruiting participants | 2 | 2026-09-03 | - |
| NCT04325828 Trial register | A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma | running, but no longer enrolling | - | 2020-03-26 | Posted |
| NCT04557059 Trial register | A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer | running, but no longer enrolling | - | 2020-09-17 | - |
| NCT07310420 Trial register | A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer | currently recruiting participants | - | 2025-12-16 | - |
| NCT07782840 Trial register | QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy | not yet recruiting participants | - | 2026-08-20 | - |
| NCT07596212 Trial register | BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexua | not yet recruiting participants | - | 2026-05-13 | - |
| NCT07777263 Trial register | ADT De-escalation in Selected High-Risk Prostate Cancer Patients (ADaPPt Trial) a GROUQ Led PCS Study (PCS XIV) | not yet recruiting participants | - | 2026-07-22 | - |
| NCT04423211 Trial register | Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging | currently recruiting participants | - | 2020-06-09 | - |
| NCT05069038 Trial register | Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy | running, but no longer enrolling | - | 2021-09-15 | - |
| NCT03701334 Trial register | A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer | running, but no longer enrolling | - | 2018-09-21 | - |
| NCT06455969 Trial register | Adaptions and Resiliency to Multi-Stressor OpeRations | currently recruiting participants | - | 2024-06-13 | - |
| NCT04513717 Trial register | Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatm | running, but no longer enrolling | - | 2020-08-14 | - |
| NCT05050084 Trial register | Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a | running, but no longer enrolling | - | 2021-09-20 | - |
| NCT03332797 Trial register | A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estro | running, but no longer enrolling | - | 2017-11-01 | - |
| NCT04126070 Trial register | Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors | running, but no longer enrolling | - | 2019-10-11 | Posted |
| 2022-501504-95-00 Trial register | A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer: ARIADNE | Not stated | 2 | - | - |
| NCT01786265 Trial register | Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer | running, but no longer enrolling | - | 2013-02-07 | - |
| NCT07127315 Trial register | Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy | completed | - | 2025-08-10 | - |
| NCT07450599 Trial register | A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Lo | currently recruiting participants | - | 2026-02-12 | - |
| 2023-510357-42-00 Trial register | A phase III, multicenter, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients | Not stated | 3 | - | - |
| NCT07751133 Trial register | Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer | not yet recruiting participants | - | 2026-07-25 | - |
| NCT06375707 Trial register | First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/H | completed | - | 2023-12-28 | - |
| NCT05879926 Trial register | Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-N | currently recruiting participants | - | 2023-05-19 | - |
| NCT07340619 Trial register | Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patient | not yet recruiting participants | - | 2025-12-18 | - |
| NCT04484818 Trial register | Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICAT | running, but no longer enrolling | - | 2020-07-24 | - |
| NCT07730151 Trial register | Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer. | not yet recruiting participants | - | 2026-07-07 | - |
| NCT02476786 Trial register | Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score | currently recruiting participants | - | 2015-06-19 | - |
| 2022-503001-38-01 Trial register | A phase IIIb study to characterize the efficacy and safety of Adjuvant ribociclib plus endocrine therapy in a close-to-clinical practice patient population with | Not stated | 3 | - | - |
| NCT06523530 Trial register | Effect of a GnRH Analog on Hepatic Steatosis | running, but no longer enrolling | - | 2024-07-26 | - |
| NCT06378866 Trial register | Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy | currently recruiting participants | - | 2024-04-23 | - |
| NCT07706933 Trial register | Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast Cancer | not yet recruiting participants | - | 2026-07-11 | - |
| NCT03942653 Trial register | Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma | running, but no longer enrolling | - | 2019-05-08 | - |
| NCT05498272 Trial register | Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select H | running, but no longer enrolling | - | 2022-07-18 | - |
| NCT03671330 Trial register | Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. | completed | - | 2018-09-14 | Posted |
| NCT05607004 Trial register | (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer | running, but no longer enrolling | - | 2022-11-07 | - |
| NCT06636591 Trial register | Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer | completed | - | 2024-10-10 | - |
| NCT02346253 Trial register | High-Dose Brachytherapy in Treating Patients With Prostate Cancer | completed | - | 2015-01-26 | - |
| NCT05628363 Trial register | Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With Hig | running, but no longer enrolling | - | 2022-11-16 | Posted |
| NCT07483658 Trial register | Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Su | currently recruiting participants | - | 2026-03-13 | - |
| NCT07313241 Trial register | Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER) | currently recruiting participants | - | 2025-12-16 | - |
| NCT03436745 Trial register | The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Thera | terminated before completion | - | 2018-02-16 | Posted |
| 2022-502046-28-00 Trial register | A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib in Combination with Phesgo® Versus | Not stated | 3 | - | - |
| NCT07158021 Trial register | Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial | currently recruiting participants | - | 2025-09-05 | - |
| NCT06922318 Trial register | The COSMYC Trial (COmbined Suppression of MYC) | currently recruiting participants | - | 2025-04-03 | - |
| NCT04961996 Trial register | A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estr | running, but no longer enrolling | - | 2021-07-05 | - |
| 2024-512360-55-00 Trial register | A randomized phase II study to evaluate the safety and efficacy of trastuzumab deruxtecan versus CDK4/6 inhibitor-based endocrine therapy as first-line therapy | Not stated | 2 | - | - |
| NCT05617885 Trial register | Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | completed | - | 2022-11-16 | - |
| NCT07477626 Trial register | Radiotherapy After Prostatectomy for Node Positive Prostate Cancer | currently recruiting participants | - | 2026-01-28 | - |
| 2023-506817-23-01 Trial register | EORTC-2238-GUCG: Intermittent Androgen deprivation Therapy in the era of AR pathway inhibitors; a phase 3 pragmatic randomized trial (DE-ESCALATE) | Not stated | 3 | - | - |
| NCT04931342 Trial register | A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors | running, but no longer enrolling | - | 2021-06-09 | - |
| 2024-514891-41-00 Trial register | A post-trial access roll-over study to allow access to ribociclib (LEE011) for patients who are on ribociclib treatment in Novartis-sponsored study | Not stated | 4 | - | - |
| 2023-507482-26-00 Trial register | PEACE 8: Combination of darolutamide and stereotactic body radiation therapy in patients with castration resistant prostate cancer and oligometastases on functi | Not stated | 3 | - | - |
| NCT05582499 Trial register | Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy | currently recruiting participants | - | 2022-10-17 | - |
| NCT07610733 Trial register | Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients. | not yet recruiting participants | - | 2026-05-14 | - |
| NCT06953882 Trial register | Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy | currently recruiting participants | - | 2025-05-01 | - |
| 2025-521911-38-00 Trial register | An open-label, multi-center, phase I/II study of GVV858 as a single agent and in combination with endocrine therapy in patients with advanced hormone receptor p | Not stated | 1/2 | - | - |
| NCT03860987 Trial register | Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate C | completed | - | 2019-03-04 | - |
| NCT00544830 Trial register | Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | running, but no longer enrolling | - | 2007-10-16 | Posted |
| NCT05085002 Trial register | A Study of Lerociclib in Participants With Advanced Breast Cancer | terminated before completion | - | 2021-09-07 | Posted |
| 2023-504031-41-00 Trial register | CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Rece | Not stated | 3 | - | - |
| NCT07553988 Trial register | A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer | running, but no longer enrolling | - | 2026-04-21 | - |
| NCT07552480 Trial register | Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic Diseases Using G | not yet recruiting participants | - | 2026-04-27 | - |
| NCT07552493 Trial register | Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic Stem Cell Transplantation Using Goserelin | not yet recruiting participants | - | 2026-04-27 | - |
| NCT07552506 Trial register | Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Goser | not yet recruiting participants | - | 2026-04-27 | - |
| NCT05206682 Trial register | Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect | currently recruiting participants | - | 2022-01-11 | - |
| 2023-506717-21-00 Trial register | Study protocol title: A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with gastrin releasing p | Not stated | 1/2 | - | - |
| 2025-520979-13-00 Trial register | NoLEEta - No chemotherapy in intermediate-risk HR+ HER2- early breast cancer treated with Ribociclib (LEE-011) in the adjuvant setting, a noninferiority Phase I | Not stated | 3 | - | - |
| NCT03361735 Trial register | Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | running, but no longer enrolling | - | 2017-12-05 | Posted |
| NCT04787744 Trial register | Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Can | currently recruiting participants | - | 2021-03-09 | - |
| NCT05694819 Trial register | Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) | completed | - | 2023-01-23 | - |
| NCT07516704 Trial register | Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate | not yet recruiting participants | - | 2026-03-25 | - |
| NCT05009290 Trial register | A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy | terminated before completion | - | 2021-08-09 | - |
| NCT06145308 Trial register | Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing | currently recruiting participants | - | 2023-11-24 | - |
| NCT06832774 Trial register | Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients | currently recruiting participants | - | 2025-01-19 | - |
| 2023-507970-42-00 Trial register | PSMAddition: An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard | Not stated | 3 | - | - |
| NCT03573648 Trial register | Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer | running, but no longer enrolling | - | 2018-06-20 | - |
| NCT06282588 Trial register | Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers | currently recruiting participants | - | 2024-01-19 | - |
| 2023-505871-63-00 Trial register | A PHASE 3 RANDOMIZED, OPEN-LABEL STUDY OF OP-1250 MONOTHERAPY VS STANDARD OF CARE FOR THE TREATMENT OF ER+, HER2- ADVANCED OR METASTATIC BREAST CANCER FOLLOWING | Not stated | 3 | - | - |
| NCT04293393 Trial register | Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients | running, but no longer enrolling | - | 2020-02-28 | Posted |
| NCT07142551 Trial register | Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response | currently recruiting participants | - | 2025-08-19 | - |
| NCT07460726 Trial register | PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermedi | not yet recruiting participants | - | 2026-02-25 | - |
| NCT07182279 Trial register | Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer | currently recruiting participants | - | 2025-08-01 | - |
| NCT00936390 Trial register | Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer | completed | - | 2009-07-08 | Posted |
| NCT01546987 Trial register | Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer | completed | - | 2012-03-03 | Posted |
| 2024-517281-42-00 Trial register | An Open-label, Multi-center, Phase I/II Study of ECI830 as a Single Agent and in Combination With Ribociclib and Endocrine Therapy in Patients With Advanced Hor | Not stated | 1/2 | - | - |
| NCT05700903 Trial register | Contributions to Hypertension With Androgen Deprivation Therapy | completed | - | 2023-01-10 | Posted |
| NCT07097259 Trial register | A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants | completed | - | 2025-07-15 | - |
| 2024-513540-29-00 Trial register | Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endoc | Not stated | 3 | - | - |
| NCT06291064 Trial register | Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer | currently recruiting participants | - | 2024-02-19 | - |
| NCT06348134 Trial register | Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery | currently recruiting participants | - | 2024-04-04 | - |
| 2023-507847-13-00 Trial register | A randomized intrapatient cross-over study to assess the efficacy of oxybutynin versus venlafaxine in REDucing hot FLASHes in women using endocrine therapy afte | Not stated | 3 | - | - |
| NCT02624973 Trial register | PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial | running, but no longer enrolling | - | 2015-12-09 | - |
| 2024-513450-30-00 Trial register | EORTC protocol 1414-ROG-GUCG: Phase IIIb randomized trial comparing irradiation plus long-term adjuvant androgen deprivation with GnRH antagonist versus GnRH ag | Not stated | 3 | - | - |
| NCT01674140 Trial register | S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | running, but no longer enrolling | - | 2012-08-28 | Posted |
| NCT06009627 Trial register | Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients | completed | - | 2023-07-18 | - |
| NCT04455750 Trial register | A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-De | running, but no longer enrolling | - | 2020-07-02 | - |
| NCT07389174 Trial register | Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer | not yet recruiting participants | - | 2025-12-28 | - |
| NCT07389187 Trial register | Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) | not yet recruiting participants | - | 2025-12-28 | - |
| NCT05701007 Trial register | Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland | completed | - | 2023-01-26 | Posted |
| NCT04734730 Trial register | Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer | currently recruiting participants | - | 2021-02-02 | - |
| NCT06059118 Trial register | Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer | currently recruiting participants | - | 2023-09-15 | - |
| NCT03056755 Trial register | Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- | completed | - | 2017-02-17 | Posted |
| NCT02454543 Trial register | Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases | running, but no longer enrolling | - | 2015-05-08 | - |
| NCT05122377 Trial register | RWE About QOL and Compliance of Patients With OFS in China | completed | - | 2021-10-29 | - |
| NCT03809000 Trial register | A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery | running, but no longer enrolling | - | 2019-01-16 | Posted |
| NCT05241860 Trial register | Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM) | running, but no longer enrolling | - | 2022-01-31 | Posted |
| NCT04034095 Trial register | A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan | completed | - | 2019-07-16 | - |
| NCT07268794 Trial register | CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer | not yet recruiting participants | - | 2025-11-16 | - |
| NCT03511196 Trial register | Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer | running, but no longer enrolling | - | 2018-04-18 | - |
| 2023-506698-36-00 Trial register | Apa/Enza short study (Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-v | Not stated | 3 | - | - |
| NCT02023463 Trial register | Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer | running, but no longer enrolling | - | 2013-12-30 | - |
| NCT03519178 Trial register | A Study of PF-06873600 in People With Cancer | terminated before completion | - | 2018-02-22 | Posted |
| NCT03822468 Trial register | Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer | completed | - | 2019-01-30 | Posted |
| NCT06528210 Trial register | Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer | withdrawn before enrolling anyone | - | 2024-05-30 | - |
| NCT02972060 Trial register | ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer | running, but no longer enrolling | - | 2016-11-21 | - |
| NCT07179939 Trial register | Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study | not yet recruiting participants | - | 2025-09-18 | - |
| NCT07172685 Trial register | Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC | currently recruiting participants | - | 2025-08-26 | - |
| NCT03678025 Trial register | Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | currently recruiting participants | - | 2018-09-19 | - |
| NCT04478266 Trial register | Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer | terminated before completion | - | 2020-07-20 | Posted |
| NCT05063786 Trial register | Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET) | running, but no longer enrolling | - | 2021-07-21 | - |
| NCT01492972 Trial register | Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer | currently recruiting participants | - | 2011-12-09 | - |
| NCT05625087 Trial register | Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Can | running, but no longer enrolling | - | 2022-11-14 | - |
| NCT02003209 Trial register | Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Oper | completed | - | 2013-12-06 | Posted |
| NCT04181203 Trial register | Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy | running, but no longer enrolling | - | 2019-11-26 | - |
| NCT02430480 Trial register | Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer | completed | - | 2015-04-30 | Posted |
| NCT06199986 Trial register | DeADT - Living Well With Prostate Cancer | completed | - | 2023-12-19 | Posted |
| NCT05513365 Trial register | Phase II Dutasteride in Combination With CAB vs CAB in SDC | currently recruiting participants | - | 2022-08-24 | - |
| 2024-510840-30-00 Trial register | EORTC-1532-GUCG: A phase 2 Randomized Open-Label Study of Oral darolutamide (ODM-201) vs. androgen deprivation therapy (ADT) with LHRH agonists or antagonist in | Not stated | 2 | - | - |
| NCT01673984 Trial register | GP Extended Action Triptorelin | terminated before completion | - | 2012-08-28 | Posted |
| NCT05333328 Trial register | OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk | currently recruiting participants | - | 2022-04-11 | - |
| NCT00328614 Trial register | Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer | completed | - | 2006-05-22 | Posted |
| NCT02278185 Trial register | Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer | completed | - | 2014-10-29 | Posted |
| NCT00567580 Trial register | Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Trea | last verified some time ago; the register no longer confirms its status | - | 2007-12-04 | Posted |
| NCT06225284 Trial register | Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients | currently recruiting participants | - | 2024-01-25 | - |
| NCT03936218 Trial register | Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer | completed | - | 2019-05-03 | - |
| NCT06929884 Trial register | Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer Patients: A R | running, but no longer enrolling | - | 2025-04-16 | - |
| NCT06050109 Trial register | The Benefits of Continued Use of Ovarian Function Suppression After 5 Years | currently recruiting participants | - | 2023-09-17 | - |
| 2022-502372-22-01 Trial register | SAFIR 03_A ctDNA screening program in patients with HR+, HER2- metastatic breast cancer for detection of high-risk relapse patients on any CDK4/6 inhibitor and | Not stated | 2 | - | - |
| 2024-510707-11-00 Trial register | Prostate-only, dose-escalated radiotherapy plus concomitant androgen deprivation therapy in primary localized, NCCN high risk and MMAI classifier low or interme | Not stated | 2 | - | - |
| NCT03944434 Trial register | FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer | running, but no longer enrolling | - | 2019-04-09 | - |
| NCT03936933 Trial register | Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer | terminated before completion | - | 2019-05-03 | - |
| 2024-512926-27-00 Trial register | A randomized phase 3, double-blind, placebo-controlled study of elacestrant plus everolimus versus elacestrant in patients with estrogen receptor-positive/human | Not stated | 3 | - | - |
| NCT00223145 Trial register | Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone | running, but no longer enrolling | - | 2005-09-13 | - |
| NCT00223171 Trial register | Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers | running, but no longer enrolling | - | 2005-09-13 | - |
| NCT05184257 Trial register | Zoladex® 10.8 BC RWS | completed | - | 2021-12-22 | - |
| NCT06772441 Trial register | Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial) | currently recruiting participants | - | 2025-01-03 | - |
| NCT02430103 Trial register | Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients | running, but no longer enrolling | - | 2015-04-30 | - |
| NCT02588404 Trial register | The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient | withdrawn before enrolling anyone | - | 2015-10-26 | - |
| NCT04992026 Trial register | The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer | completed | - | 2021-07-28 | - |
| NCT02685397 Trial register | Management of Castration-Resistant Prostate Cancer with Oligometastases | running, but no longer enrolling | - | 2016-02-18 | - |
| NCT04551495 Trial register | Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) | last verified some time ago; the register no longer confirms its status | - | 2020-09-16 | - |
| NCT04657679 Trial register | Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts | terminated before completion | - | 2020-11-20 | Posted |
| NCT02366494 Trial register | Micro RNAs to Predict Response to Androgen Deprivation Therapy | completed | - | 2015-02-19 | - |
| 2023-503676-25-01 Trial register | Progression under Olaparib: a randomized phaSE II trIal with docetaxel or carboplatin-docetaxel DOublet in mCRPC patieNts | Not stated | 2 | - | - |
| 2024-516204-42-00 Trial register | Selecting the optimal position of CDK4/6 inhibitors in HR+ advanced breast cancer: the SONIA trial | Not stated | 3 | - | - |
| NCT01964170 Trial register | A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer | completed | - | 2013-10-17 | - |
| NCT06656624 Trial register | Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HE | currently recruiting participants | - | 2024-10-23 | - |
| NCT03839823 Trial register | Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal P | completed | - | 2019-02-15 | Posted |
| NCT05594095 Trial register | SNF Platform Study of HR+/ HER2-advanced Breast Cancer | currently recruiting participants | - | 2022-10-26 | - |
| NCT03867357 Trial register | Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia | completed | - | 2019-02-26 | - |
| NCT06575257 Trial register | Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer | currently recruiting participants | - | 2024-08-28 | - |
| NCT05163106 Trial register | Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole | completed | - | 2021-12-20 | - |
| NCT06483386 Trial register | Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer | not yet recruiting participants | - | 2024-06-12 | - |
| NCT04862143 Trial register | Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combin | terminated before completion | - | 2021-04-27 | Posted |
| NCT05720260 Trial register | Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC | currently recruiting participants | - | 2023-02-09 | - |
| NCT06447623 Trial register | Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer | currently recruiting participants | - | 2024-06-03 | - |
| NCT02344472 Trial register | Detect V / CHEVENDO (Chemo vs. Endo) | last verified some time ago; the register no longer confirms its status | - | 2015-01-26 | - |
| NCT06385847 Trial register | To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2024-04-26 | - |
| NCT06387056 Trial register | Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) | currently recruiting participants | - | 2024-04-26 | - |
| NCT03272477 Trial register | Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment U | completed | - | 2017-09-05 | - |
| NCT01942135 Trial register | Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) | completed | - | 2013-09-10 | Posted |
| 2023-509167-24-00 Trial register | BYLieve: A phase II, multicenter, open-label, three-cohort, non-comparative study to assess the efficacy and safety of alpelisib plus fulvestrant or letrozole i | Not stated | 2 | - | - |
| NCT03423199 Trial register | PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY | last verified some time ago; the register no longer confirms its status | - | 2018-02-06 | - |
| NCT03007979 Trial register | Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer | completed | - | 2017-01-02 | Posted |
| NCT03311555 Trial register | A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical P | completed | - | 2017-09-26 | Posted |
| NCT04536467 Trial register | Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients | last verified some time ago; the register no longer confirms its status | - | 2020-09-02 | - |
| NCT00295646 Trial register | Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid | completed | - | 2006-02-24 | Posted |
| NCT02278120 Trial register | Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer | completed | - | 2014-10-29 | Posted |
| NCT05149131 Trial register | A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer | completed | - | 2021-11-25 | - |
| NCT05891093 Trial register | Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) | currently recruiting participants | - | 2023-05-24 | - |
| NCT05949541 Trial register | Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer | currently recruiting participants | - | 2023-07-09 | - |
| NCT03899077 Trial register | Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP | last verified some time ago; the register no longer confirms its status | - | 2019-04-02 | - |
| NCT00099086 Trial register | Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer | completed | - | 2004-12-08 | - |
| NCT01394263 Trial register | Study of Histrelin Subdermal Implant in Patients With Prostate Cancer | completed | - | 2011-07-14 | - |
| NCT06177015 Trial register | Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC | currently recruiting participants | - | 2023-12-11 | - |
| NCT03664895 Trial register | Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial) | last verified some time ago; the register no longer confirms its status | - | 2018-09-07 | - |
| NCT02594072 Trial register | Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT) | last verified some time ago; the register no longer confirms its status | - | 2015-10-26 | - |
| NCT00482807 Trial register | Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer | completed | - | 2007-06-05 | - |
| NCT05781217 Trial register | Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624 | currently recruiting participants | - | 2023-03-23 | - |
| NCT00541047 Trial register | RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery | completed | - | 2007-10-08 | - |
| NCT02941926 Trial register | Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2 | completed | - | 2016-10-21 | Posted |
| NCT04465097 Trial register | Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer | completed | - | 2020-06-30 | - |
| NCT06080620 Trial register | The Choice of Treatment Methods and Efficacy of LABC | last verified some time ago; the register no longer confirms its status | - | 2023-09-21 | - |
| NCT01377389 Trial register | Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | terminated before completion | - | 2011-06-21 | Posted |
| NCT02221999 Trial register | Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients | running, but no longer enrolling | - | 2014-07-14 | - |
| NCT00002889 Trial register | Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer | completed | - | 2004-04-22 | - |
| NCT05983107 Trial register | Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer | currently recruiting participants | - | 2023-07-18 | - |
| NCT00651326 Trial register | Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer | terminated before completion | - | 2008-04-02 | - |
| NCT00664456 Trial register | Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer | completed | - | 2008-04-22 | - |
| NCT03193060 Trial register | A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Imp | completed | - | 2017-06-20 | - |
| NCT05945407 Trial register | Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer | currently recruiting participants | - | 2023-03-26 | - |
| NCT00309478 Trial register | Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients | completed | - | 2006-04-03 | - |
| NCT02015871 Trial register | An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer | completed | - | 2013-12-19 | - |
| NCT05898321 Trial register | To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone | last verified some time ago; the register no longer confirms its status | - | 2023-02-10 | - |
| NCT02333370 Trial register | A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With G | completed | - | 2015-01-07 | - |
| NCT00771017 Trial register | Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer | withdrawn before enrolling anyone | - | 2008-10-10 | - |
| NCT05801705 Trial register | Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive E | last verified some time ago; the register no longer confirms its status | - | 2023-03-26 | - |
| NCT05110170 Trial register | Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX® | completed | - | 2021-11-03 | - |
| NCT05140512 Trial register | Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® | completed | - | 2021-11-03 | - |
| NCT05856630 Trial register | Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg | last verified some time ago; the register no longer confirms its status | - | 2023-05-12 | - |
| NCT02058706 Trial register | LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer | completed | - | 2014-02-10 | Posted |
| NCT05800197 Trial register | Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia | last verified some time ago; the register no longer confirms its status | - | 2023-04-05 | - |
| NCT00432172 Trial register | Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients | completed | - | 2007-02-07 | Posted |
| NCT03440879 Trial register | Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose | terminated before completion | - | 2018-02-01 | - |
| NCT03447132 Trial register | Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant | completed | - | 2018-02-27 | - |
| NCT03969121 Trial register | Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer | completed | - | 2019-05-13 | - |
| NCT00430183 Trial register | Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer | running, but no longer enrolling | - | 2007-02-01 | Posted |
| NCT00055731 Trial register | Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse | completed | - | 2003-03-07 | - |
| NCT02914158 Trial register | Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women | last verified some time ago; the register no longer confirms its status | - | 2016-09-26 | - |
| NCT00004124 Trial register | S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | completed | - | 2003-01-27 | Posted |
| NCT02440230 Trial register | Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients | completed | - | 2015-05-02 | - |
| NCT03971110 Trial register | A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy. | terminated before completion | - | 2019-03-21 | - |
| NCT04356430 Trial register | Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2020-04-22 | - |
| NCT04130152 Trial register | Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy | completed | - | 2019-10-14 | - |
| NCT02064036 Trial register | Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate | completed | - | 2014-02-17 | - |
| NCT01717053 Trial register | Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer | completed | - | 2012-10-26 | Posted |
| NCT02789878 Trial register | Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer | completed | - | 2016-06-03 | - |
| NCT05406999 Trial register | Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer | currently recruiting participants | - | 2022-05-29 | - |
| NCT03279250 Trial register | Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer | completed | - | 2017-09-07 | Posted |
| NCT01989780 Trial register | Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer | completed | - | 2013-11-21 | - |
| NCT05439499 Trial register | This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Co | last verified some time ago; the register no longer confirms its status | - | 2022-06-30 | - |
| NCT05438810 Trial register | This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With | last verified some time ago; the register no longer confirms its status | - | 2022-06-30 | - |
| NCT00005044 Trial register | Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | completed | - | 2000-04-06 | Posted |
| NCT03628066 Trial register | Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer | completed | - | 2018-08-14 | - |
| NCT04894188 Trial register | Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer | currently recruiting participants | - | 2021-05-20 | - |
| NCT05304169 Trial register | Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. | completed | - | 2022-03-11 | - |
| NCT05212857 Trial register | Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2022-01-28 | - |
| NCT05253066 Trial register | Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer | last verified some time ago; the register no longer confirms its status | - | 2022-02-23 | - |
| NCT02626507 Trial register | Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer | last verified some time ago; the register no longer confirms its status | - | 2015-12-07 | - |
| NCT02586675 Trial register | TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer | completed | - | 2015-10-26 | Posted |
| NCT00116220 Trial register | Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer | completed | - | 2005-06-27 | - |
| NCT02535221 Trial register | Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer | currently recruiting participants | - | 2015-08-28 | - |
| NCT05131893 Trial register | Neoadjuvant Treatment of Breast Cancer | not yet recruiting participants | - | 2021-11-23 | - |
| NCT02592031 Trial register | Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women | completed | - | 2015-10-28 | - |
| NCT05013242 Trial register | Goserline Acetate VS Dienogest in Endometriosi | last verified some time ago; the register no longer confirms its status | - | 2021-04-20 | - |
| NCT03096847 Trial register | Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer | completed | - | 2017-03-30 | Posted |
| NCT01252693 Trial register | International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men W | completed | - | 2010-12-03 | - |
| NCT02907918 Trial register | Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer | terminated before completion | - | 2016-09-20 | Posted |
| NCT04563936 Trial register | Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® | completed | - | 2020-09-21 | - |
| NCT05004142 Trial register | Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin | last verified some time ago; the register no longer confirms its status | - | 2021-08-13 | - |
| NCT02603679 Trial register | Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases | running, but no longer enrolling | - | 2015-11-13 | - |
| NCT04248621 Trial register | Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients | last verified some time ago; the register no longer confirms its status | - | 2020-01-30 | - |
| NCT02917005 Trial register | PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer | last verified some time ago; the register no longer confirms its status | - | 2016-09-28 | - |
| NCT02867020 Trial register | Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testoste | completed | - | 2016-08-08 | - |
| NCT00003653 Trial register | Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer | completed | - | 2003-01-27 | - |
| NCT02518191 Trial register | Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity | completed | - | 2015-08-05 | Posted |
| NCT03658213 Trial register | To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. | withdrawn before enrolling anyone | - | 2018-06-27 | - |
| NCT04060043 Trial register | Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer | completed | - | 2019-08-16 | - |
| NCT03717870 Trial register | Surgery and ART For Endometrioma | not yet recruiting participants | - | 2018-10-22 | - |
| NCT00104715 Trial register | Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer | completed | - | 2005-03-04 | - |
| NCT04736108 Trial register | Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate | last verified some time ago; the register no longer confirms its status | - | 2021-02-03 | - |
| NCT04203212 Trial register | BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH | completed | - | 2019-12-18 | - |
| NCT04622761 Trial register | Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitax | last verified some time ago; the register no longer confirms its status | - | 2020-09-29 | - |
| NCT00303784 Trial register | Prostate Adenocarcinoma TransCutaneous Hormones | last verified some time ago; the register no longer confirms its status | - | 2006-03-17 | - |
| NCT00970203 Trial register | Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | completed | - | 2009-09-01 | Posted |
| NCT00004054 Trial register | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | completed | - | 1999-12-10 | Posted |
| NCT02472275 Trial register | PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer | completed | - | 2015-06-11 | - |
| NCT02059213 Trial register | A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer | completed | - | 2014-02-07 | Posted |
| NCT01280045 Trial register | Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy | terminated before completion | - | 2011-01-10 | - |
| NCT01738724 Trial register | Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin | terminated before completion | - | 2012-11-30 | - |
| NCT02168062 Trial register | Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer | terminated before completion | - | 2014-06-20 | Posted |
| NCT02592083 Trial register | Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors | running, but no longer enrolling | - | 2015-10-30 | - |
| NCT02742675 Trial register | Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | last verified some time ago; the register no longer confirms its status | - | 2016-04-19 | - |
| NCT04428684 Trial register | COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg | completed | - | 2020-06-11 | - |
| NCT00003645 Trial register | Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence | terminated before completion | - | 2003-07-15 | Posted |
| NCT00002633 Trial register | Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer | completed | - | 2003-01-27 | - |
| NCT01790126 Trial register | The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer | completed | - | 2013-02-08 | Posted |
| NCT02532400 Trial register | Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients | terminated before completion | - | 2015-08-17 | - |
| NCT02058381 Trial register | A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer | completed | - | 2014-01-16 | - |
| NCT02217566 Trial register | Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol | completed | - | 2014-08-13 | Posted |
| NCT04220398 Trial register | Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2020-01-02 | - |
| NCT00068601 Trial register | S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer | completed | - | 2003-09-11 | Posted |
| NCT00937768 Trial register | Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy | terminated before completion | - | 2009-07-13 | Posted |
| NCT00114114 Trial register | Dose-Response of Gonadal Steroids and Bone Turnover in Older Men | completed | - | 2005-06-14 | Posted |
| NCT00186121 Trial register | Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women | completed | - | 2005-09-16 | Posted |
| NCT04116827 Trial register | Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device | last verified some time ago; the register no longer confirms its status | - | 2019-10-03 | - |
| NCT03587285 Trial register | A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2018-07-16 | - |
| NCT00669162 Trial register | Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer | completed | - | 2008-04-24 | Posted |
| NCT00850941 Trial register | Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | last verified some time ago; the register no longer confirms its status | - | 2009-02-23 | - |
| NCT00528866 Trial register | Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy | completed | - | 2007-09-10 | Posted |
| NCT01163084 Trial register | Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer | terminated before completion | - | 2010-07-15 | Posted |
| NCT03054168 Trial register | Systemic Hormones and Muscle Protein Synthesis | last verified some time ago; the register no longer confirms its status | - | 2017-02-10 | - |
| NCT03450109 Trial register | A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer | completed | - | 2018-03-01 | - |
| NCT01073865 Trial register | Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer | completed | - | 2010-02-22 | Posted |
| NCT03137368 Trial register | A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 M | last verified some time ago; the register no longer confirms its status | - | 2017-04-24 | - |
| NCT03696186 Trial register | Selective Treatment According to Molecular Subtype of Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2018-10-03 | - |
| NCT01638247 Trial register | Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients | completed | - | 2012-07-09 | - |
| NCT00298155 Trial register | Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer | completed | - | 2006-03-01 | Posted |
| NCT00283803 Trial register | Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer | completed | - | 2006-01-26 | Posted |
| NCT03591549 Trial register | Fulvestrant in Metastatic Breast Cancer | last verified some time ago; the register no longer confirms its status | - | 2018-07-09 | - |
| NCT00165399 Trial register | Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment | completed | - | 2005-09-09 | - |
| NCT00002597 Trial register | Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | completed | - | 1999-11-01 | Posted |
| NCT00004635 Trial register | Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer | completed | - | 2000-02-21 | Posted |
| NCT00423475 Trial register | Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer | completed | - | 2007-01-18 | - |
| NCT01776008 Trial register | Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer | terminated before completion | - | 2013-01-25 | Posted |
| NCT03475758 Trial register | Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide | last verified some time ago; the register no longer confirms its status | - | 2018-03-23 | - |
| NCT01496131 Trial register | Tecemotide (L-BLP25) in Prostate Cancer | completed | - | 2011-12-21 | Posted |
| NCT01120236 Trial register | Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer | completed | - | 2010-05-10 | Posted |
| NCT03444025 Trial register | Neoadjuvant Goserelin for Triple Negative Breast Cancer | last verified some time ago; the register no longer confirms its status | - | 2018-02-23 | - |
| NCT03373708 Trial register | Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer | last verified some time ago; the register no longer confirms its status | - | 2017-12-14 | - |
| NCT02483767 Trial register | Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer | completed | - | 2015-06-29 | - |
| NCT00589472 Trial register | Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer | completed | - | 2008-01-09 | Posted |
| NCT02911350 Trial register | Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer | completed | - | 2016-08-29 | - |
| NCT01712893 Trial register | Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer | completed | - | 2012-10-21 | - |
| NCT01023061 Trial register | Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer | completed | - | 2009-12-02 | Posted |
| NCT00225420 Trial register | Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer | completed | - | 2005-09-23 | Posted |
| NCT00658697 Trial register | Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer | completed | - | 2008-04-09 | Posted |
| NCT02107391 Trial register | Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer | completed | - | 2014-04-08 | - |
| NCT00170157 Trial register | Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer | completed | - | 2005-09-15 | Posted |
| NCT01266213 Trial register | Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women | last verified some time ago; the register no longer confirms its status | - | 2010-12-24 | - |
| NCT00438321 Trial register | Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome | terminated before completion | - | 2007-02-20 | - |
| NCT00002651 Trial register | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | completed | - | 2003-01-27 | Posted |
| NCT00769795 Trial register | Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer | completed | - | 2008-10-09 | - |
| NCT00769548 Trial register | Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer | completed | - | 2008-10-09 | - |
| NCT01750398 Trial register | Bipolar Androgen-based Therapy for Prostate Cancer (BAT) | completed | - | 2012-12-17 | Posted |
| NCT00081159 Trial register | Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metast | completed | - | 2004-04-08 | Posted |
| NCT00776594 Trial register | Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy | completed | - | 2008-10-20 | Posted |
| NCT00220194 Trial register | A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg | completed | - | 2005-09-22 | - |
| NCT02932761 Trial register | Comparison of the Therapeutic Effects of VR and VR + GnRHa in the Treatment of Cesarean Scar Diverticula | last verified some time ago; the register no longer confirms its status | - | 2016-10-08 | - |
| NCT01120262 Trial register | S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin | completed | - | 2010-05-10 | - |
| NCT01076335 Trial register | Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer | completed | - | 2010-02-24 | Posted |
| NCT00021450 Trial register | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | completed | - | 2003-01-27 | - |
| NCT02544191 Trial register | GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia | last verified some time ago; the register no longer confirms its status | - | 2015-08-29 | - |
| NCT02678520 Trial register | Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | withdrawn before enrolling anyone | - | 2016-01-06 | - |
| NCT00006359 Trial register | Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer | completed | - | 2000-10-04 | - |
| NCT00439751 Trial register | Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy | completed | - | 2007-02-26 | - |
| NCT00016913 Trial register | Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | completed | - | 2003-01-27 | Posted |
| NCT02779387 Trial register | Reproductive Outcome of EM Treated by GnRH-a Associated With Laparoscopy | last verified some time ago; the register no longer confirms its status | - | 2016-05-20 | - |
| NCT00429403 Trial register | Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer | terminated before completion | - | 2007-01-31 | Posted |
| NCT02749825 Trial register | Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | terminated before completion | - | 2012-05-08 | - |
| NCT00586898 Trial register | Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle | completed | - | 2007-12-21 | Posted |
| NCT01603420 Trial register | External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer | terminated before completion | - | 2012-05-18 | Posted |
| NCT00010010 Trial register | Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer | completed | - | 2004-04-21 | - |
| NCT01530607 Trial register | Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer | completed | - | 2012-02-10 | - |
| NCT00454571 Trial register | Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer | completed | - | 2007-03-30 | Posted |
| NCT02661789 Trial register | Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression | completed | - | 2016-01-22 | - |
| NCT00067015 Trial register | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | completed | - | 2003-08-11 | - |
| NCT00108732 Trial register | A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate C | completed | - | 2005-04-19 | Posted |
| NCT01744366 Trial register | One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population | completed | - | 2012-12-06 | - |
| NCT01242748 Trial register | A Degarelix Trial in Patients With Prostate Cancer | terminated before completion | - | 2010-11-17 | Posted |
| NCT01149356 Trial register | RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer | terminated before completion | - | 2010-06-23 | - |
| NCT00851461 Trial register | Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy | completed | - | 2009-02-26 | - |
| NCT00500110 Trial register | Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer | completed | - | 2007-07-12 | Posted |
| NCT01368263 Trial register | Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer | terminated before completion | - | 2011-06-07 | Posted |
| NCT01682642 Trial register | The Influence of Adjuvant Medical Treatment of Peritoneal Endometriosis on the Outcome of IVF. A Prospective Randomized Analysis. | completed | - | 2012-08-23 | Posted |
| NCT02382094 Trial register | Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radia | completed | - | 2015-03-05 | - |
| NCT00631527 Trial register | Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | completed | - | 2008-03-07 | - |
| NCT00666666 Trial register | R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer | completed | - | 2008-04-24 | Posted |
| NCT00053911 Trial register | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | terminated before completion | - | 2003-02-06 | - |
| NCT02313051 Trial register | Everolimus trIal for Advanced prememopausaL Breast Cancer Patients | last verified some time ago; the register no longer confirms its status | - | 2014-12-09 | - |
| NCT01531205 Trial register | Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA | terminated before completion | - | 2012-02-08 | Posted |
| NCT00349557 Trial register | Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer | completed | - | 2006-07-07 | - |
| NCT02132390 Trial register | Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Ch | last verified some time ago; the register no longer confirms its status | - | 2014-05-07 | - |
| NCT00946920 Trial register | A Trial of Degarelix in Patients With Prostate Cancer | completed | - | 2009-07-27 | Posted |
| NCT01088529 Trial register | Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer | completed | - | 2010-03-15 | Posted |
| NCT00805701 Trial register | Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation | completed | - | 2008-12-05 | - |
| NCT02072512 Trial register | The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer | last verified some time ago; the register no longer confirms its status | - | 2014-02-26 | - |
| NCT00938496 Trial register | Non-Interventional Study of Zoladex in Endometriosis | completed | - | 2009-07-09 | - |
| NCT01250717 Trial register | Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer | completed | - | 2010-11-23 | Posted |
| NCT00767286 Trial register | Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | completed | - | 2008-10-07 | - |
| NCT00884273 Trial register | Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients | completed | - | 2009-04-20 | Posted |
| NCT00831233 Trial register | Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer | terminated before completion | - | 2009-01-28 | Posted |
| NCT00002580 Trial register | Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | completed | - | 2004-03-11 | - |
| NCT00348998 Trial register | Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2006-07-06 | - |
| NCT01622361 Trial register | Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer | last verified some time ago; the register no longer confirms its status | - | 2012-06-13 | - |
| NCT00026377 Trial register | SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | completed | - | 2004-02-06 | - |
| NCT01240928 Trial register | MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer | withdrawn before enrolling anyone | - | 2010-11-15 | - |
| NCT01240941 Trial register | Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer | withdrawn before enrolling anyone | - | 2010-11-15 | - |
| NCT00002460 Trial register | Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer | last verified some time ago; the register no longer confirms its status | - | 2004-06-09 | - |
| NCT00427245 Trial register | Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer | completed | - | 2007-01-29 | - |
| NCT00002582 Trial register | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | completed | - | 2003-07-08 | - |
| NCT00028769 Trial register | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | completed | - | 2003-01-27 | Posted |
| NCT00031850 Trial register | Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer | completed | - | 2003-01-27 | - |
| NCT00003394 Trial register | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | completed | - | 2004-04-30 | - |
| NCT00012090 Trial register | Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum | completed | - | 2003-11-11 | - |
| NCT00047099 Trial register | Combination Chemotherapy in Treating Women With Breast Cancer | completed | - | 2003-01-27 | - |
| NCT01013506 Trial register | Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer | withdrawn before enrolling anyone | - | 2009-11-13 | - |
| NCT00498901 Trial register | Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer | terminated before completion | - | 2007-07-11 | - |
| NCT01020604 Trial register | PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients | completed | - | 2009-11-20 | - |
| NCT01813097 Trial register | Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer | completed | - | 2013-03-12 | - |
| NCT00512668 Trial register | Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer | terminated before completion | - | 2007-08-08 | - |
| NCT00217659 Trial register | S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer | withdrawn before enrolling anyone | - | 2005-09-22 | - |
| NCT00967018 Trial register | A Long Term Safety Study of Degarelix in Patients With Prostate Cancer | completed | - | 2009-08-27 | Posted |
| NCT00833248 Trial register | Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer | completed | - | 2009-02-02 | Posted |
| NCT00014586 Trial register | Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer | terminated before completion | - | 2003-01-27 | - |
| NCT01205685 Trial register | Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer | terminated before completion | - | 2010-09-20 | Posted |
| NCT00605267 Trial register | Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment | completed | - | 2008-01-31 | Posted |
| NCT00388804 Trial register | External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | terminated before completion | - | 2006-10-17 | Posted |
| NCT00849082 Trial register | Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer | completed | - | 2009-02-23 | - |
| NCT01014507 Trial register | Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma | completed | - | 2009-11-17 | - |
| NCT01581944 Trial register | Gonadotropin-releasing Hormone Agonist Prior to Myomectomy | completed | - | 2012-04-20 | - |
| NCT00653757 Trial register | Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | completed | - | 2008-04-07 | - |
| NCT00827307 Trial register | Zoladex Plus Tamoxifen in Breast Cancer | completed | - | 2009-01-22 | - |
| NCT00532272 Trial register | Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC | completed | - | 2007-09-20 | - |
| NCT01352091 Trial register | Adjuvant AI Combined With Zoladex | last verified some time ago; the register no longer confirms its status | - | 2011-05-10 | - |
| NCT00654524 Trial register | Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis | last verified some time ago; the register no longer confirms its status | - | 2008-04-08 | - |
| NCT00322348 Trial register | Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women | completed | - | 2006-05-05 | Posted |
| NCT00235937 Trial register | Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex | completed | - | 2005-10-12 | - |
| NCT00692874 Trial register | Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy | completed | - | 2008-06-05 | - |
| NCT00888082 Trial register | Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy | withdrawn before enrolling anyone | - | 2009-04-24 | - |
| NCT00002881 Trial register | Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | completed | - | 2004-08-24 | - |
| NCT00398489 Trial register | Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | last verified some time ago; the register no longer confirms its status | - | 2006-11-10 | - |
| NCT00746031 Trial register | Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids | completed | - | 2008-09-03 | - |
| NCT01218581 Trial register | Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis | completed | - | 2010-10-11 | - |
| NCT00196846 Trial register | Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) | completed | - | 2005-09-20 | - |
| NCT00433173 Trial register | Insulin Sensitivity in Men With the Metabolic Syndrome | suspended | - | 2007-02-09 | - |
| NCT00523484 Trial register | Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts | completed | - | 2007-08-30 | - |
| NCT00303524 Trial register | Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients | completed | - | 2006-03-17 | - |
| NCT00761683 Trial register | Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS | terminated before completion | - | 2008-09-26 | - |
| NCT00948805 Trial register | Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Ini | last verified some time ago; the register no longer confirms its status | - | 2009-07-23 | - |
| NCT00912548 Trial register | Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women | last verified some time ago; the register no longer confirms its status | - | 2009-06-03 | - |
| NCT00703768 Trial register | Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year | last verified some time ago; the register no longer confirms its status | - | 2008-06-19 | - |
| NCT00841113 Trial register | Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer | completed | - | 2009-02-11 | - |
| NCT00167648 Trial register | Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer | completed | - | 2005-09-14 | - |
| NCT00382057 Trial register | Testosterone Effects on Men With the Metabolic Syndrome | withdrawn before enrolling anyone | - | 2006-09-28 | - |
| NCT00540059 Trial register | Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial | completed | - | 2007-10-03 | - |
| NCT00536653 Trial register | Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer | completed | - | 2007-09-28 | - |
| NCT00255268 Trial register | CMAB vs IMAB in Metastatic Prostate Cancer | withdrawn before enrolling anyone | - | 2005-11-18 | - |
| NCT00488722 Trial register | A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsiv | last verified some time ago; the register no longer confirms its status | - | 2007-06-19 | - |
| NCT00293696 Trial register | Casodex/Zoladex Biomarkers in Localised Prostate Cancer | completed | - | 2006-02-17 | - |
| NCT00286351 Trial register | Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis | completed | - | 2006-02-01 | - |
| NCT00293670 Trial register | FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2006-02-17 | - |
Source: ClinicalTrials.gov and EU CTIS, read 2026-10-03. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.